| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |